US2023250420A1PendingUtilityA1

Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells using microcarriers

Assignee: INSCRIPTA INCPriority: Apr 24, 2020Filed: Feb 24, 2023Published: Aug 10, 2023
Est. expiryApr 24, 2040(~13.7 yrs left)· nominal 20-yr term from priority
C12N 15/1082C12M 41/36C12M 33/14C12N 15/113C12N 15/86C12M 23/42C12M 27/10C12M 29/04C12M 43/00C12M 47/02C12N 5/0696C12N 15/1065C12N 15/1068C12N 15/11C12N 15/88C12N 15/907B01L 3/502761B01L 7/00C12M 23/12C12M 23/16C12M 23/50C12M 47/04C12N 9/22C12N 15/102C12N 2310/20C12M 35/08C12M 25/16B01L 2200/0647B01L 2300/0681B01L 3/502769B01L 2300/123B01L 2300/161B01L 2400/0421B01L 2400/0424C12N 2750/14143C12N 2740/16043C12N 15/90C12N 2740/10011C12N 2510/00C12N 2750/14111B01L 2400/0415C12N 2740/15011C12N 2800/80
85
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions of matter, methods, modules, and automated instruments may relate to synthesizing a library including an editing cassette including a different gRNA and donor DNA pair, amplifying the editing cassette in a partition separate from other editing cassettes in the library, adding nuclease to the partition, and adding lipofectamine to the editing cassette and nuclease to form a lipofectamine/nucleic acid/nuclease complex. A microcarrier coated in extracellular matrix or a cell adhesion molecule coating may be added to the lipofectamine/nucleic acid/nuclease complex. Cell growth material, the microcarrier, and mammalian cells may be transferred to a growth module in an automated closed cell editing instrument via a liquid handling system. The mammalian cells may be allowed to seed on the microcarrier. Conditions may be provided for the mammalian cells to take-up and be edited by a payload associated with the lipofectamine/nucleic acid/nuclease complex. The mammalian cells may be detached from the microcarrier.

Claims

exact text as granted — not AI-modified
1 . A method for transfecting and performing nucleic acid-guided nuclease editing in mammalian cells in an automated closed cell editing instrument comprising the steps of comprising the steps of:
 synthesizing a library of editing cassettes off instrument, wherein each editing cassette comprises a different gRNA and donor DNA pair;   amplifying each editing cassette in the library of editing cassettes in a partition separate from other editing cassettes;   adding nuclease to each partition with an amplified editing cassette;   adding lipofectamine to each amplified editing cassette and nuclease to form a library of lipofectamine/nucleic acid/nuclease complexes;   adding microcarriers to each lipofectamine/nucleic acid/nuclease complex in the library of lipofectamine/nucleic acid/nuclease complexes, wherein the microcarriers are coated in extracellular matrix or a cell adhesion molecule coating and wherein the lipofectamine/nucleic acid/nuclease complexes bind to the microcarriers;   transferring cell growth medium, the microcarriers and mammalian cells to a growth module in the automated closed cell editing instrument via a liquid handling system;   allowing the cells to seed on the coated microcarriers in the growth module;   providing conditions for the cells to take-up the lipofectamine/nucleic acid/nuclease payloads in the growth module;   providing conditions for the nucleic acids and nuclease to edit the cells in the growth module; and   detaching the edited cells from the microcarriers.   
     
     
         2 - 30 . (canceled)

Join the waitlist — get patent alerts

Track US2023250420A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.